02 Mar 2018
Medlab Clinical on track for analytical release of Nanabis pain management medicine

Medlab Clinical Ltd (ASX:MDC), a developer of cannabis based medicines, has made solid progress with its proprietary pain management product, Nanabis.

READ FULL ARTICLE HERE

CHEWING GUM COMPOSITION CANNABINOIDS & OPIOID AGONISTS / ANTAGANISTS

26 Jun 2019

READ FULL ARTICLE HERE  

NASAL CANNABIDIOL COMPOSITIONS - INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT

26 Jun 2019

Related Applications [0001] This application...

Medlab Clinical on track for analytical release of Nanabis pain management medicine

26 Jun 2019

02 Mar 2018Medlab Clinical on track for...

Geocann Launches Cannabidiol (CBD) Soft Gel Formulations Utilizing Patented Drug Delivery Technology

26 Jun 2019

Condition-specific portfolio showcases...

Afriplex Gears Up For SA’s Cannabis Explosion

17 Apr 2019

Afriplex, the Paarl-based botanicals ingredient...

ASTM International and ICCI Sign MOU on Cannabis Standards

12 Dec 2018

ASTM International and the International...